StonvexLoading…
StonvexStonvexStonvexCore line items from CPHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $59.57M | $61.56M | $61.44M | $66.82M |
Operating Income | $2.46M | $6.43M | $11.50M | $10.89M |
Net Income | $-529.43K | $2.11M | $10.56M | $7.51M |
EPS (Diluted) | $-0.10 | $0.42 | $2.13 | $1.54 |
Total Assets | $112.58M | $109.92M | $104.68M | $92.28M |
Total Liabilities | $28.70M | $25.83M | $22.88M | $21.09M |
Cash & Equivalents | $12.06M | $10.08M | $21.94M | $12.99M |
Free Cash Flow OCF − CapEx | $4.72M | $-5.50M | $3.63M | $6.22M |
Shares Outstanding | 5.12M | 5.04M | 4.96M | 4.89M |